October 12, 2016

New findings challenge current view of how pancreas cancer develops

The findings provide important insights into how pancreas cancer develops and spreads and new strategies for better understanding one of the mostly deadly types of cancer.

Toronto (October 12, 2016) – Researchers in the multidisciplinary PanCuRx research initiative at the Ontario Institute for Cancer Research (OICR) and University Health Network’s Princess Margaret Cancer Centre, led by Dr. Faiyaz Notta and Dr. Steven Gallinger, today published new findings that challenge current beliefs about how and why pancreas cancer is so aggressive.

Read More >

October 6, 2016

Reactome announces annotation and release of 10,000th human protein

The data are being shared with the wider biological research community to help in the development of new therapies for diseases like cancer.

Read More >

August 17, 2016

New retrospective study aims to identify mutations to better diagnose breast cancer in the future

Mr. Peter Goodhand, President of The Ontario Institute for Cancer Research (OICR), today announced a new collaborative research study in partnership with Thermo Fisher Scientific and Queen’s University to help bring more targeted diagnosis and treatment to breast cancer patients in the future.

Read More >

July 14, 2016

International team launches community competition to unravel how cancer changes a cell’s RNA

Scientists from around the world have announced a new challenge to find the best algorithms for detecting all of the abnormal RNA molecules in a cancer cell. This is a community effort, inviting all scientists and enthusiasts to participate in a collaborative crowd-sourced benchmarking effort.

Read More >

June 28, 2016

Researchers discover protein signatures for accurate non-invasive diagnosis of aggressive prostate cancer

Researchers at the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) in Toronto, along with researchers at the Eastern Virginia Medical School, have created protein signatures that accurately diagnose prostate cancer and can distinguish between patients with aggressive versus non-aggressive disease using a simple urine sample.

Read More >

June 6, 2016

Researchers discover protein signatures for accurate non-invasive diagnosis of aggressive prostate cancer

Public launch of NCI-funded cancer-knowledge platform will bridge silos and enable broad collaboration among researchers

Read More >

June 1, 2016

Clinical trial launched to test use of MRI to improve prostate cancer diagnosis and management

The Movember Foundation, the Ontario Institute for Cancer Research (OICR) and Prostate Cancer Canada today announced $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer.

Read More >

May 26, 2016

Privacy Analytics Acquired by IMS Health

Integrating innovative data privacy expertise with a global healthcare information & technology service leader, strengthening and driving Ontario’s digital healthcare security footprint  

Read More >

May 4, 2016

$2 million in new funding from Canadian Institutes of Health Research will help Ontario team study metabolic syndromes

Dr. Janet Dancey, Scientific Director of the Canadian Cancer Clinical Trials Network (3CTN) announced today the roll out of a new national campaign to raise awareness of cancer clinical trials in Canada ahead of International Clinical Trials Day on May 20.

Read More >

May 2, 2016

International Cancer Genome Consortium for Medicine (ICGCmed) launches today, will link genomics to clinical information and health

Toronto – (May 2, 2016) Dr. Philip Awadalla, Senior Investigator at the Ontario Institute for Cancer Research and Principal Investigator for the Ontario Health Study has been awarded $2 million by the Canadian Institutes of Health Research.

Read More >

April 17, 2016

International Cancer Genome Consortium for Medicine (ICGCmed) launches today, will link genomics to clinical information and health

New Orleans – (April 17, 2016) The International Cancer Genome Consortium (ICGC) today announced plans to launch the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the Consortium’s evolution that will link genomics to clinical information and health.

Read More >

April 6, 2016

Dr. John Dick elected as 2016 Fellow of the AACR Academy

Toronto (April 6, 2016) – Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today congratulated Dr. John Dick on receiving the prestigious honour of being one of 11 newly elected Fellows to the AACR (American Association for Cancer Research) Academy.

Read More >

March 31, 2016

Dana-Farber Cancer Institute and Ontario Institute for Cancer Research join Collaborative Cancer Cloud

PORTLAND, Ore. – The Knight Cancer Institute at Oregon Health & Science University and Intel Corporation are expanding participation in the Collaborative Cancer Cloud, a distributed precision medicine analytics platform, to include Dana-Farber Cancer Institute and Ontario Institute for Cancer Research.

Read More >

March 1, 2016

International Cancer Genome Consortium reaches milestone of 1,000 authorized users

TORONTO, March 1, 2016 /CNW/ - The International Cancer Genome Consortium (ICGC) announced today that its Data Access Compliance Office (DACO) authorized its 1,000th user, giving them access to the Consortium's Controlled Access datasets.

Read More >

February 4, 2016

Stand Up To Cancer Canada Announces New Cancer Stem Cell Dream Team To Attack Brain Cancer in Children and Adults

Pan-Canadian Team of Researchers Will Receive CA $11.7 Million in Funding from Stand Up To Cancer Canada, Genome Canada, Canadian Institutes of Health Research, Cancer Stem Cell Consortium, and Ontario Institute for Cancer Research

Read More >

February 3, 2016

Real time outbreak surveillance using genomics now possible in resource-limited conditions

New research published in Nature has shown how genome sequencing can be rapidly established to monitor outbreaks.


Read More >

January 7, 2016

Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario

Five promising early stage research projects that would benefit from OICR’s input and expertise were selected from a province-wide call for proposals.

Read More >

December 16, 2015

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

Image-guided medicines for hard to treat cancers built using next generation medical isotopes

Read More >

December 9, 2015

Building the foundations for Cancer Genomic Analysis for Research and Clinical Diagnostics

A study published in the prestigious journal Nature Communications revealed a high degree of heterogeneity in how cancer genome sequencing is done at different institutions across the globe;

Read More >

December 8, 2015

FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

First-in-class epigenetic modifiers discovered by OICR positioned for collaborative development

Read More >

November 18, 2015

The International Cancer Genome Consortium brings more genomic health data to researchers on the Amazon Web Services Cloud

The International Cancer Genome Consortium (ICGC) announced today that 1,200 encrypted cancer whole genome sequences are now securely available on the Amazon Web Services (AWS) Cloud for access by cancer researchers worldwide.

Read More >

November 16, 2015

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research

An open challenge that merges the efforts of the world’s largest cancer genome sequencing consortia, the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) with those of Sage Bionetworks and DREAM.

Read More >

October 28, 2015

FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management

Versant Ventures-led investment accelerates development, broadens oncolytic viral immunotherapy potential.


Read More >

October 14, 2015

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

Research Collaboration and Option and License Agreement Reach Approximately $450 Million Cdn


Read More >

September 3, 2015

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research

Toronto, ON - Researchers from the Ontario Institute for Cancer Research (OICR) and the Structural Genomics Consortium (SGC) at the MaRS Discovery District in Toronto have developed a new drug prototype called OICR-9429 and made it freely available to...

Read More >

July 28, 2015

The Centre for Drug Research and Development (CDRD) and the Ontario Institute for Cancer Research (OICR) team up to advance cutting-edge new cancer treatments

Vancouver, BC and Toronto, ON - Two of Canada’s leading drug research and commercialization centres have announced a call for proposals to help bring new cancer treatments to patients through collaborative technology-development projects from...

Read More >

July 10, 2015

Cancer patients treated in world-first clinical trial of Canadian viral therapy

OTTAWA/CNW/ - Canadian researchers have launched the world's first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional...

Read More >

July 9, 2015

World-leading Big Data researchers call for support for more accessible and more effective storage of data in the cloud to facilitate genomics research

Toronto, ON - Today in the journal Nature prominent researchers from Canada, Europe and the U.S. have made a powerful call to major funding agencies, asking them to commit to establishing a global genomic data commons in the cloud that could be easily accessed...

Read More >

June 15, 2015

Researchers sequence and assemble first full genome of a living organism using technology the size of smartphone

Toronto, ON - Researchers in Canada and the U.K. have for the first time sequenced and assembledde novo the full genome of a living organism, the bacteria Escherichia Coli, using Oxford Nanopore’s MinIONTM device, a genome sequencer that can fit in the palm of...

Read More >

June 1, 2015

The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research

Toronto, ON - Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today announced OICR is investing $4.6 million over two years in PanCuRx, an initiative that seeks solutions to the high fatality rate of pancreatic cancer...

Read More >

May 25, 2015

Groundbreaking Research Moves One Step Closer to Personalizing Prostate Cancer Treatment

Toronto, ON - The results of groundbreaking genetics research in Canada, funded by the Movember Foundation, the Ontario Institute for Cancer Research (OICR) and Prostate Cancer Canada (PCC), has identified a unique sub-type of prostate cancer that will help clinicians develop more personalized treatments for their patients, ensure that fewer men undergo unnecessary treatments and improve...

Read More >

May 18, 2015

Research community comes together to provide new “gold standard” for genomic data analysis

Toronto, ON - Cancer research leaders at the Ontario Institute for Cancer Research, Oregon Health & Science University, Sage Bionetworks, the distributed DREAM (Dialog for Reverse Engineering Assessment and Methods) community and The University of...

Read More >

March 9, 2015

Ontario Institute for Cancer Research scientist wins 2014 Roger Cotton Prize for Histopathology

Toronto, ON - Dr. Tom Hudson, President and Scientific Director of The Ontario Institute for Cancer Research (OICR) today congratulated Mary Anne Quintayo, recipient of the 2014 Roger Cotton Prize for Histopathology for her paper on virtual tissue...

Read More >

February 25, 2015

OICR extends collaboration with Janssen Inc. to develop clinical trials for prostate cancer

Toronto, ON - The Ontario Institute for Cancer Research (OICR) is extending its collaborative research partnership with Janssen Inc. to develop more multi-centre clinical trials and other translational research projects that address important clinical questions in prostate cancer...

Read More >

February 4, 2015

ICGC launches six new projects from Australia, France, Germany, Japan and Singapore

Toronto, ON - Today, World Cancer Day, the International Cancer Genome Consortium (ICGC) announced six new projects from Australia, France, Germany, Japan and Singapore. These projects seek to identify the genomic drivers in melanoma, uterine, lung, bile duct, gastric...

Read More >

January 13, 2015

Canadian Cancer Clinical Trials Network receives new funding, launches online service to connect patients to clinical trials

Toronto, ON - Dr. Janet Dancey, Scientific Director of the Canadian Cancer Clinical Trials Network (3CTN), today announced that 3CTN has received funding support from the Ontario Institute for Cancer Research (OICR), the Canadian Partnership Against Cancer (the Partnership)...

Read More >